Loading clinical trials...
Loading clinical trials...
Comparing the efficacy and safety of fludarabine-containing BFC conditioning regimen with traditional BuCy conditioning regimen in Acute B-cell lymphoblastic leukemia patients who treated with allogen...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
NCT07569055 · Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT06093867 · Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT07101588 · Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT05534620 · Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), and more
NCT07013370 · Immunoglobulin Prophylaxis, Cytomegalovirus Infections, and more
Shanghai General Hospital
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions